BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17294161)

  • 1. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.
    Schaaf HS; Victor TC; Engelke E; Brittle W; Marais BJ; Hesseling AC; van Helden PD; Donald PR
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):203-5. PubMed ID: 17294161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
    Lemus D; Echemendía M; Díaz R; Llop A; Llanes MJ
    Biomedica; 2014 Apr; 34 Suppl 1():108-13. PubMed ID: 24968042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
    AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
    Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis drug resistance in isolates of Mycobacterium tuberculosis complex in southeast Spain.
    Montiel Quezel-Guerraz N; Sánchez-Porto A; Ortega Torres M; Pérez Santos MJ; Acosta F; Guzman A; Correa Ruiz A; Bérmudez Ruiz P
    J Glob Antimicrob Resist; 2020 Mar; 20():183-186. PubMed ID: 31421285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the GenoType MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
    Saglik I; Oz Y; Kiraz N
    Indian J Med Microbiol; 2014; 32(3):318-22. PubMed ID: 25008829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Köser CU; Summers DK; Archer JA
    J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
    Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
    Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the microplate nitrate reductase assay and the rezasurin microtitre assay for the rapid detection of multidrug resistant Mycobacterium tuberculosis clinical isolates.
    Coban AY; Uzun M; Akgunes A; Durupinar B
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):578-81. PubMed ID: 22850946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
    Parsons LM; Salfinger M; Clobridge A; Dormandy J; Mirabello L; Polletta VL; Sanic A; Sinyavskiy O; Larsen SC; Driscoll J; Zickas G; Taber HW
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2218-25. PubMed ID: 15917515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
    Kurbatova EV; Cavanaugh JS; Shah NS; Wright A; Kim H; Metchock B; Van Deun A; Barrera L; Boulahbal F; Richter E; Martín-Casabona N; Arias F; Zemanova I; Drobniewski F; Santos Silva A; Coulter C; Lumb R; Cegielski JP
    Int J Tuberc Lung Dis; 2012; 16(3):355-7. PubMed ID: 22640449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.